Revenue decreased 100.0%
Revenue changed -100.0% from the comparable as-filed period.
$1.3M→$02 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →INBX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding increased 1.6%
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
14,485,421→14,717,6604 prior comparisons
Cash & equivalents decreased 28.5%
Cash & equivalents changed -28.5% from the comparable as-filed period.
$186.6M→$133.3M3 prior comparisons
Operating income decreased 17.4%
Operating income changed -17.4% from the comparable as-filed period.
-$27.4M→-$32.1M2 prior comparisons
Current liabilities decreased 27.9%
Current liabilities changed -27.9% from the comparable as-filed period.
$38.9M→$28.1M3 prior comparisons
Noncurrent long-term debt increased 77.6%
Noncurrent long-term debt changed +77.6% from the comparable as-filed period.
$99.3M→$176.3M2 prior comparisons
Total assets decreased 27.3%
Total assets changed -27.3% from the comparable as-filed period.
$212.1M→$154.2M3 prior comparisons
Current assets decreased 26.7%
Current assets changed -26.7% from the comparable as-filed period.
$194.0M→$142.2M3 prior comparisons
Working capital decreased 26.4%
Working capital changed -26.4% from the comparable as-filed period.
$155.0M→$114.1M3 prior comparisons
Free-cash-flow proxy increased 0.1%
Free-cash-flow proxy changed +0.1% from the comparable as-filed period.
-$30.0M→-$29.9M3 prior comparisons
Operating cash flow increased 0.1%
Operating cash flow changed +0.1% from the comparable as-filed period.
-$30.0M→-$29.9M3 prior comparisons
Working capital / assets moved 93 bp higher
Working capital / assets changed +93 basis points from the comparable as-filed period.
73.08%→74.02%3 prior comparisons
Stock-based compensation increased 12.1%
Stock-based compensation changed +12.1% from the comparable as-filed period.
$2.8M→$3.1M3 prior comparisons
Research & development increased 7.3%
Research & development changed +7.3% from the comparable as-filed period.
$22.3M→$23.9M2 prior comparisons
Current ratio increased 1.7%
Current ratio changed +1.7% from the comparable as-filed period.
4.98→5.073 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$03 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.